|
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Segment Reporting Information [Line Items] | ||||
| External sales | $ 75,083 | $ 74,662 | $ 150,108 | $ 152,258 |
| Earnings before income taxes | 37,446 | 37,873 | 75,432 | 78,373 |
|
Biotechnology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 69,628 | 69,808 | 139,131 | 142,111 |
| Earnings before income taxes | 36,883 | 37,878 | 73,877 | 77,862 |
|
Hematology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 5,455 | 4,854 | 10,977 | 10,147 |
| Earnings before income taxes | 2,148 | 1,681 | 4,251 | 3,599 |
|
Reportable Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | 39,031 | 39,559 | 78,128 | 81,461 |
|
Unallocated Amount to Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | $ (1,585) | $ (1,686) | $ (2,696) | $ (3,088) |